THOMPSONNICOLA PLANNINGBusiness Directories,Company Directories

Company Name: Corporate Name:	THOMPSON-NICOLA PLANNING
Company Title:
Company Description:
Keywords to Search:
Company Address:	2079 Falcon Rd,KAMLOOPS,BC,Canada
ZIP Code: Postal Code:	V2C4J2
Telephone Number:	2503729336
Fax Number:	2503725048
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	9121-04
USA SIC Description:	Government Offices-City, Villa
Number of Employees:	Unknown
Sales Amount:
Credit History: Credit Report:	Institution
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
THOMPSON-NICOLA TOURISM
THOMPSON-NICOLA LIBRARY SVC
THOMPSON-NICOLA MOSQUITO ADVSR

Next company profile:
THOMPSON-NICOLA PLANNING
THOMPSON-NICOLA PLANNING
THOMPSON-NICOLA DISTRICT LIB

Company News:

Vasant Narasimhan - Wikipedia
Vasant " Vas " Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis [1][2][3][4] He succeeded Joseph Jimenez who left Novartis in 2018 [5]
Vasant Narasimhan | Novartis
Vasant (Vas) Narasimhan, M D , has been Chief Executive Officer (CEO) of Novartis since February 1, 2018
Vas Narasimhan - Reimagining medicine as CEO of Novartis | LinkedIn
At Novartis, we’re reimagining medicine with innovative science and technology to address some of society’s most intractable and long-standing health issues
Novartis CEO and Key Executive Team - Craft. co
Novartis's Chief Executive Officer is Vasant Narasimhan Other executives include Kees Roks, Chief Audit Officer; Harry Kirsch, Chief Financial Officer and 21 others See the full leadership team at Craft
HIGHLIGHTS: Vasant Narasimhan - CEO of Novartis | Norges Bank . . .
Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, and how Novartis transformed from a sprawling conglomerate into a streamlined drug discovery company
Vasant Narasimhan | CEO of Novartis | Leader in Global Healthcare
Vasant Narasimhan is at the forefront of the pharmaceutical industry as CEO of Novartis His innovation makes an impact on global health
TIME100 Health: Vas Narasimhan | TIME
In 2018, he became CEO of Novartis and seized the opportunity to direct the company’s vast resources for transformative change
CEO Watch Vasant Narasimhan - Novartis | WhatJobs News
Vasant Narasimhan has served as CEO of Novartis since 2018, leading the Swiss pharmaceutical giant through a period of innovation, digital transformation, and strategic realignment
Vasant Narasimhan - Indiaspora
Dr Vasant Narasimhan is an American physician currently serving as the CEO of Novartis, a multinational pharmaceutical giant He is known for his focus on innovation and access to medicines, particularly in developing countries
Novartis CEO Vas Narasimhan named to 2025 TIME100 Health list
Novartis has announced that CEO Vas Narasimhan, M D , has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health